Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
DNA med-focused biotech Seawolf surfaces with $1.2B Sanofi pact
Gene therapy biotech Seawolf has emerged from the deep with $100 million to fuel its DNA therapeutic ambitions and a billion-dollar deal with Sanofi.
Michael Gibney
Nov 16, 2026 5:00am
Sanofi-backed Windward hits $225M IPO, as Rezera delays listing
Nov 13, 2026 7:10am
Sanofi scraps Nurix program 2 months after entering clinic
Nov 4, 2026 5:02am
Sanofi mulling ‘moonshot’ M&A targets to survive Dupixent cliff
Oct 30, 2026 3:27am
Sanofi pays Regeneron $1B for 4 early-stage assets to ignite R&D
Oct 1, 2026 4:24am
Owkin, Servier ink oncology trial and discovery deal
Sep 11, 2026 2:01pm